Clinical Trial

Characterization of Abdomino-pelvic Lesions by 18Fluorine- Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Study acronym: 18F-FDG PET/CT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to identify and characterize lesions in the abdominopelvic region detected by 18fluorine- fluorodeoxyglucose (FDG) positron Emission Tomography combined Computed Tomography (PET/CT) scan, including determining their malignant or benign nature, and to determine the extent of disease to facilitate proper management
Trial Details
NCT Number NCT07127627
Lead Sponsor Assiut University
Conditions Abdominal Sepsis
Enrollment 79 participants
Start Date 2025-08
Primary Completion 2028-10 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2025-08-17